Market Overview The global companion diagnostics market is experiencing significant growth fueled by the accelerating adoption of precision medicine and targeted therapies across oncology and beyond. The global companion diagnostics market is projected to surpass USD 10 billion through 2030, driven by increasing demand for biomarker-driven treatment decisions, expanding regulatory...

Point-of-care testing driving INAAT adoption — isothermal nucleic acid amplification technologies (INAAT) — including loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), recombinase polymerase amplification (RPA), and other non-PCR amplification methodologies — enabling rapid pathogen detection at constant temperature without thermal...

Cancer diagnostics expanding NAT applications — the emerging application of molecular diagnostics and nucleic acid detection technology to cancer diagnostics — including circulating tumor DNA (ctDNA) detection, minimal residual disease (MRD) monitoring through blood-based liquid biopsy, and tumor-specific mutation analysis — creating a premium diagnostics market segment whose...

The Spain Clinical Laboratory Services Market is transforming diagnostic testing by providing blood tests, molecular diagnostics, genetic testing, microbiology, and pathology services enabling early disease detection, accurate diagnoses, treatment monitoring, and personalized medicine for Spanish patients. At the core of clinical laboratory services is diagnostic accuracy. Clinical...

According to the latest report published by Data Bridge Market Research, the Third Generation Sequencing Market  CAGR Value Data Bridge Market Research analyses that the third generation sequencing market which was USD 9.01 billion in 2022, is expected to reach USD 28.73 billion by 2030, at a CAGR of 15.60% during the forecast period 2023 to 2030 The winning Third Generation...